Effects of Integrated Moral Reasoning Development Intervention for Management of Violence in Schizophrenia
NCT ID: NCT05207319
Last Updated: 2022-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
43 participants
INTERVENTIONAL
2019-09-01
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of an Integrated Multimodal Lifestyle Intervention for Management of Violence in Schizophrenia
NCT05229484
Exploring the Effectiveness of Group Cognitive Stimulation Therapy in People With Schizophrenia.
NCT04916483
Prediction of Violent Behavior in Patients With Schizophrenia by Multimodal Machine Learning
NCT04520399
NMDA-enhancing Treatment for Cognitive Dysfunction of Schizophrenia
NCT06021197
The Establishment of the Early Intervention Program for Patients With Schizophrenia
NCT00172770
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The triggering point of violence is multi-faceted and dynamic. Many risk factors for violence intertwined and interacted at multiple levels. This integrated moral reasoning development intervention, when applied in conjunction with psychiatric standard care, could display synergistic and effective effects on moral reasoning and ethical evaluation, and impulsivity and personality features of repetitive violence in patients with schizophrenia. Suggestions for future research are made. There is a need to concurrently examine moral reasoning, violence and conflict handling styles in a dyadic context such as vSZ patients and their family members involved, so that a whole picture of the violence can be better observed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
the MRDI group (Moral Reasoning Development Intervention)
The MRDI is comprised of 4 components that are run concurrently: moral reasoning, strategies of anger management and problem-solving and social skills.
integrated Moral Reasoning Development Intervention (MRDI)
The MRDI is comprised of 4 components that are run concurrently: moral reasoning, strategies of anger management and problem-solving and social skills.
the control group
The control group is the Treatment as Usual (TAU).
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
integrated Moral Reasoning Development Intervention (MRDI)
The MRDI is comprised of 4 components that are run concurrently: moral reasoning, strategies of anger management and problem-solving and social skills.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Psychiatrically hospitalized
* Repetitive violence within one year
* Having basic literacy
* More than 20 years old
* Less than 65 years old
Exclusion Criteria
20 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
I-Shou University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mei-Chi Hsu
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mei-Chi Hsu, Ph.D
Role: PRINCIPAL_INVESTIGATOR
I-Shou University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
I-Shou University
Kaohsiung City, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IShouU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.